Pacira BioSciences Company Insiders

PCRX Stock  USD 26.02  0.02  0.08%   
Pacira BioSciences employs about 788 people. The company is managed by 20 executives with a total tenure of roughly 43 years, averaging almost 2.0 years of service per executive, having 39.4 employees per reported executive. Break down of Pacira BioSciences' management performance can provide insight into the company performance.
David Stack  Chairman
Chairman and CEO
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacira BioSciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Pacira Stock please use our How to Invest in Pacira BioSciences guide.

Pacira BioSciences Management Team Effectiveness

The company has return on total asset (ROA) of 0.0289 % which means that it generated a profit of $0.0289 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.029 %, meaning that it created $0.029 on every $100 dollars invested by stockholders. Pacira BioSciences' management efficiency ratios could be used to measure how well Pacira BioSciences manages its routine affairs as well as how well it operates its assets and liabilities.
The majority of Pacira BioSciences outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Pacira BioSciences to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Pacira BioSciences. Please pay attention to any change in the institutional holdings of Pacira BioSciences as this could imply that something significant has changed or is about to change at the company.
Some institutional investors establish a significant position in stocks such as Pacira BioSciences in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Pacira BioSciences, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Pacira BioSciences Workforce Comparison

Pacira BioSciences is regarded second in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 5,324. Pacira BioSciences retains roughly 788 in number of employees claiming about 15% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.03 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.07 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.07.

Pacira BioSciences Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Pacira BioSciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Pacira BioSciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Pacira BioSciences insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Pacira BioSciences Notable Stakeholders

A Pacira BioSciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Pacira BioSciences often face trade-offs trying to please all of them. Pacira BioSciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Pacira BioSciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Frank LeeCEO DirectorProfile
David StackChairman and CEOProfile
Richard KahrVice ResourcesProfile
Daryl GauglerChief OfficerProfile
Charles LaranjeiraChief Technical OfficerProfile
Christopher YoungChief OfficerProfile
Shawn CrossChief OfficerProfile
JD EsqChief SecretaryProfile
DO EllisChief OfficerProfile
III CPAChief OfficerProfile
Max ReinhardtPres WorldProfile
Dennis McLoughlinChief Commercial OfficerProfile
Kristen JDChief SecretaryProfile
Brendan TeehanChief OfficerProfile
Krys EsqChief OfficerProfile
Roy MDChief OfficerProfile
Susan MescoIR Contact OfficerProfile
Jonathan MDChief OfficerProfile
Lauren RikerPrincipal FinanceProfile
Esq IIIChief OfficerProfile
String symbol = request.getParameter("s");

About Pacira BioSciences Management Performance

The success or failure of an entity such as Pacira BioSciences often depends on how effective the management is. Pacira BioSciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Pacira management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Pacira management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida. Pacira Pharm operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 697 people.
Please note, the imprecision that can be found in Pacira BioSciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Pacira BioSciences. Check Pacira BioSciences' Beneish M Score to see the likelihood of Pacira BioSciences' management manipulating its earnings.

Pacira BioSciences Workforce Analysis

Traditionally, organizations such as Pacira BioSciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Pacira BioSciences within its industry.

Pacira BioSciences Manpower Efficiency

Return on Pacira BioSciences Manpower

Revenue Per Employee889.6K
Revenue Per Executive35M
Net Loss Per Employee126.3K
Net Loss Per Executive5M
Working Capital Per Employee552.3K
Working Capital Per Executive21.8M

Additional Tools for Pacira Stock Analysis

When running Pacira BioSciences' price analysis, check to measure Pacira BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences is operating at the current time. Most of Pacira BioSciences' value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences' price. Additionally, you may evaluate how the addition of Pacira BioSciences to your portfolios can decrease your overall portfolio volatility.